171 related articles for article (PubMed ID: 25155925)
1. Cyclosporine A regulates pro-inflammatory cytokine production in ulcerative colitis.
Steiner S; Daniel C; Fischer A; Atreya I; Hirschmann S; Waldner M; Neumann H; Neurath M; Atreya R; Weigmann B
Arch Immunol Ther Exp (Warsz); 2015 Feb; 63(1):53-63. PubMed ID: 25155925
[TBL] [Abstract][Full Text] [Related]
2. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
[TBL] [Abstract][Full Text] [Related]
3. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
Kobayashi T; Okamoto S; Hisamatsu T; Kamada N; Chinen H; Saito R; Kitazume MT; Nakazawa A; Sugita A; Koganei K; Isobe K; Hibi T
Gut; 2008 Dec; 57(12):1682-9. PubMed ID: 18653729
[TBL] [Abstract][Full Text] [Related]
4. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis.
Kirman I; Nielsen OH
Am J Gastroenterol; 1996 Sep; 91(9):1789-94. PubMed ID: 8792700
[TBL] [Abstract][Full Text] [Related]
5. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
[TBL] [Abstract][Full Text] [Related]
6. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis.
Lampinen M; Backman M; Winqvist O; Rorsman F; Rönnblom A; Sangfelt P; Carlson M
J Leukoc Biol; 2008 Dec; 84(6):1392-9. PubMed ID: 18801925
[TBL] [Abstract][Full Text] [Related]
7. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis.
Jugde F; Alizadeh M; Boissier C; Chantry D; Siproudhis L; Corbinais S; Quelvennec E; Dyard F; Campion JP; Gosselin M; Bretagne JF; Sémana G; Heresbach D
Eur Cytokine Netw; 2001; 12(3):468-77. PubMed ID: 11566628
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.
Ten Hove T; The Olle F; Berkhout M; Bruggeman JP; Vyth-Dreese FA; Slors JF; Van Deventer SJ; Te Velde AA
J Leukoc Biol; 2004 Jun; 75(6):1010-5. PubMed ID: 15020649
[TBL] [Abstract][Full Text] [Related]
10. Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis.
Dahlén R; Strid H; Lundgren A; Isaksson S; Raghavan S; Magnusson MK; Simrén M; Sjövall H; Öhman L
Scand J Immunol; 2013 Sep; 78(3):275-84. PubMed ID: 23713660
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of interleukin-12 receptor beta(2) on lamina propria mononuclear cells of patients with active Crohn's disease.
Stallmach A; Marth T; Adrian N; Wittig BM; Ecker KW; Schilling M; Zeitz M
Int J Colorectal Dis; 2002 Sep; 17(5):303-10. PubMed ID: 12172923
[TBL] [Abstract][Full Text] [Related]
12. Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients.
Candia E; Díaz-Jiménez D; Langjahr P; Núñez LE; de la Fuente M; Farfán N; López-Kostner F; Abedrapo M; Alvarez-Lobos M; Pinedo G; Beltrán CJ; González C; González MJ; Quera R; Hermoso MA
Immunobiology; 2012 Jun; 217(6):634-42. PubMed ID: 22101184
[TBL] [Abstract][Full Text] [Related]
13. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
14. Contribution of TIA-1+ and granzyme B+ cytotoxic T lymphocytes to cryptal apoptosis and ulceration in active inflammatory bowel disease.
Mitomi H; Ohkura Y; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Fukui N; Kanazawa H; Kishimoto I; Saigenji K
Pathol Res Pract; 2007; 203(10):717-23. PubMed ID: 17869012
[TBL] [Abstract][Full Text] [Related]
15. The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs).
Vadasz Z; Rainis T; Nakhleh A; Haj T; Bejar J; Halasz K; Toubi E
PLoS One; 2015; 10(5):e0125860. PubMed ID: 25978359
[TBL] [Abstract][Full Text] [Related]
16. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
17. Visilizumab induces apoptosis of mucosal T lymphocytes in ulcerative colitis through activation of caspase 3 and 8 dependent pathways.
Yu QT; Saruta M; Papadakis KA
Clin Immunol; 2008 Jun; 127(3):322-9. PubMed ID: 18424236
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis.
Hölttä V; Klemetti P; Salo HM; Koivusalo A; Pakarinen M; Westerholm-Ormio M; Kolho KL; Vaarala O
J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):287-92. PubMed ID: 23974060
[TBL] [Abstract][Full Text] [Related]
19. IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease.
Belarif L; Danger R; Kermarrec L; Nerrière-Daguin V; Pengam S; Durand T; Mary C; Kerdreux E; Gauttier V; Kucik A; Thepenier V; Martin JC; Chang C; Rahman A; Guen NS; Braudeau C; Abidi A; David G; Malard F; Takoudju C; Martinet B; Gérard N; Neveu I; Neunlist M; Coron E; MacDonald TT; Desreumaux P; Mai HL; Le Bas-Bernardet S; Mosnier JF; Merad M; Josien R; Brouard S; Soulillou JP; Blancho G; Bourreille A; Naveilhan P; Vanhove B; Poirier N
J Clin Invest; 2019 Apr; 129(5):1910-1925. PubMed ID: 30939120
[TBL] [Abstract][Full Text] [Related]
20. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]